CC
TTPH

CQS Cayman’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

CQS Cayman’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,500
Closed -$9.01M – 203
2015
Q2 		$9.01M Buy
9,500
+7,000
+280% +$5.72M 0.54% 51
2015
Q1 		$1.83M Sell
2,500
-1,129
-31% -$848K 0.09% 135
2014
Q4 		$2.88M Buy
+3,629
New +$1.95M 0.19% 92

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

CQS Cayman's TTPH Position: Q3 2015 in Review

CQS Cayman sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 9,500 shares — an estimated $9.01M sold.

CQS Cayman first reported a position in TTPH in Q4 2014 and held it in 3 quarters. The position peaked at $9.01M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

  • CQS Cayman reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • CQS Cayman sold 9,500 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $9.01M.
  • CQS Cayman first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 3 quarters.
  • CQS Cayman's Tetraphase Pharmaceuticals, Inc. position peaked at $9.01M in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on CQS Cayman's 13F filing for Q3 2015, filed 30 Oct 2015.